Key | % Net Assets |
---|---|
SAP | 4.1% |
Novartis | 3.5% |
Bureau Veritas | 3.4% |
Essilor | 3.3% |
Other | 85.7% |
Name | % Net Assets |
---|---|
SAP | 4.1% |
Novartis | 3.5% |
Bureau Veritas | 3.4% |
Essilor | 3.3% |
Sanofi | 3.3% |
Unilever | 3.3% |
Brenntag | 3.2% |
Syngenta | 3.1% |
DnB NOR Bank | 2.9% |
Vopak | 2.8% |
No asset data available.
Date | 25-Apr-2024 |
---|---|
NAV | 156.40p |
Currency | GBP |
Change | -3.00p |
% | -1.88% |
YTD change | -9.10p |
YTD % | -5.50% |
Fund Inception | 03/10/2003 |
---|---|
Fund Manager | Leon Howard-Spink |
TER | 1.68 (15-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.15 |
You are here: research